MAXIPIME

This brand name is authorized in Estonia, Hong Kong, Japan, Lithuania, Mexico, South Africa

Active ingredients

The drug MAXIPIME contains one active pharmaceutical ingredient (API):

1 Cefepime dihydrochloride monohydrate UNII 2A1O4F5N0C - CEFEPIME HYDROCHLORIDE ANHYDROUS

Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases. Read about Cefepime

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DE01	Cefepime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DE Fourth-generation cephalosporins
Discover more medicines within J01DE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1024670
Country: HK	Department of Health Drug Office	Identifier(s): 39153
Country: JP	医薬品医療機器総合機構	Identifier(s): 6132425D1024, 6132425D2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1011943
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 128M95
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/20.1.1/0722, 28/20.1.1/0723, 28/20.1.1/0724